PHARMA 5 (0535.836.710): financials and annual accounts

PHARMA 5

Etterbeek ·KBO/BCE: BE 0535.836.710

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Balance sheet: assets
`20/58`	359,207	304,133	325,541	318,054	382,113	480,374	583,707	613,524	665,240	718,034	790,224	923,416
`21/28`	4,197	4,330	4,462	36,827	106,827	176,375	246,375	318,858	394,037	460,965	534,609	607,752
`21`	-	-	0	20,500	61,500	102,500	143,500	184,500	225,500	266,500	307,500	348,500
`22/27`	2,370	2,502	2,635	14,500	43,500	72,500	101,500	133,858	168,037	193,965	226,609	259,252
`24`	2,370	2,502	2,635	14,500	43,500	72,500	101,500	133,858	166,215	188,500	217,500	246,500
`26`	-	-	-	-	-	-	-	-	1,822	5,465	9,109	12,752
`28`	1,827	1,827	1,827	1,827	1,827	1,375	1,375	500	500	500	500	-
`29/58`	355,010	299,804	321,079	281,227	275,286	303,999	337,332	294,666	271,203	257,069	255,616	315,663
`3`	277,405	232,464	204,326	188,322	187,525	198,159	178,612	171,806	178,635	157,355	165,513	119,447
`30/36`	277,405	232,464	204,326	188,322	187,525	198,159	178,612	171,806	178,635	157,355	165,513	119,447
`40/41`	33,707	27,970	40,576	29,761	33,474	34,299	25,577	28,241	29,412	46,355	38,415	89,048
`40`	33,653	27,839	40,444	27,940	28,080	17,192	20,591	20,472	19,014	28,995	18,948	33,209
`41`	54	132	132	1,821	5,394	17,108	4,986	7,769	10,398	17,360	19,468	55,839
`54/58`	40,915	39,370	73,565	62,755	53,694	67,424	129,546	89,916	58,705	49,339	47,607	105,331
`490/1`	2,983	0	2,612	388	593	4,117	3,597	4,704	4,452	4,020	4,081	1,837
Balance sheet: equity and liabilities
`10/49`	359,207	304,133	325,541	318,054	382,113	480,374	583,707	613,524	665,240	718,034	790,224	923,416
`10/15`	-1.1m	-1.1m	-1.1m	-1.1m	-1.1m	-995,874	-929,383	-885,529	-792,224	-625,599	-486,246	-345,741
`10/11`	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600
`100`	-	-	-	-	-	-	18,600	18,600	18,600	18,600	18,600	18,600
`14`	-1.1m	-1.2m	-1.2m	-1.1m	-1.1m	-1.0m	-947,983	-904,129	-810,824	-644,199	-504,846	-364,341
`17/49`	1.5m	1.5m	1.5m	1.4m	1.4m	1.5m	1.5m	1.5m	1.5m	1.3m	1.3m	1.3m
`17`	0	3,500	0	35,568	121,504	183,971	231,547	311,246	388,655	463,839	536,862	607,786
`170/4`	-	-	0	14,568	100,504	183,971	231,547	311,246	388,655	463,839	536,862	607,786
`178/9`	0	3,500	0	21,000	21,000	-	-	-	-	-	-	-
`42/48`	1.3m	1.3m	1.4m	1.3m	1.3m	1.3m	1.3m	1.1m	1.0m	864,085	730,135	661,370
`42`	8,646	0	14,568	85,936	90,736	86,366	79,700	77,409	75,184	73,023	70,924	68,885
`43`	-	-	0	63	-	-	-	-	27	-	-	-
`430/8`	-	-	0	63	-	-	-	-	27	-	-	-
`44`	302,641	404,997	427,928	540,647	492,822	448,645	468,668	413,580	310,942	314,463	420,551	406,020
`440/4`	302,641	404,997	427,928	540,647	492,822	448,645	468,668	413,580	310,942	314,463	420,551	406,020
`45`	55,830	46,927	62,972	57,767	45,417	65,713	49,186	24,921	30,242	27,083	28,453	19,320
`450/3`	6,651	889	6,769	19,011	12,057	14,370	12,133	343	2,586	2,995	617	105
`454/9`	49,179	46,038	56,203	38,755	33,359	51,343	37,054	24,578	27,655	24,088	27,836	19,216
`47/48`	925,583	852,169	861,036	633,031	644,828	665,354	671,159	633,648	622,574	449,517	210,207	167,145
`492/3`	190,770	145,185	99,182	64,278	39,050	26,200	12,831	38,249	29,841	15,709	9,473	-
Income statement
`76A`	526	4,607	417	1,568	2,499	1,609	6,053	2,127	498	-	109	1,873
`9900`	441,067	386,513	355,678	390,880	355,093	312,374	291,371	228,614	151,461	207,348	192,653	-1,471
`62`	361,078	341,531	321,343	330,123	296,491	279,805	226,257	216,631	204,537	235,626	223,139	214,850
`630`	133	133	35,019	70,000	70,000	70,000	73,358	75,179	77,001	73,643	73,643	111,498
`640/8`	1,126	1,107	1,058	1,044	1,021	1,018	592	1,958	1,266	1,718	862	4,653
`66A`	4,173	1,341	343	54	14,064	273	7,202	-	667	28	4,296	562
`9901`	74,558	42,400	-2,084	-10,341	-26,483	-38,722	-16,038	-65,154	-132,010	-103,667	-104,991	-332,472
`75/76B`	362	431	924	259	740	231	277	187	733	1,905	1,116	140
`75`	362	431	924	259	740	231	277	187	733	1,905	1,116	140
`65/66B`	50,451	51,265	39,677	36,842	30,562	27,938	28,009	28,187	35,298	37,591	32,444	33,320
`65`	50,451	51,265	39,677	36,842	30,562	27,938	28,009	28,187	35,298	37,591	32,444	33,320
`9903`	24,470	-8,433	-40,838	-46,924	-56,305	-66,428	-43,770	-93,154	-166,575	-139,353	-140,505	-364,341
`67/77`	88	65	72	68	65	64	84	151	50	-	-	-
`9904`	24,381	-8,498	-40,909	-46,992	-56,371	-66,491	-43,854	-93,305	-166,625	-139,353	-140,505	-364,341
`9905`	24,381	-8,498	-40,909	-46,992	-56,371	-66,491	-43,854	-93,305	-166,625	-139,353	-140,505	-364,341
Appropriation of the result
`9906`	-1.1m	-1.2m	-1.2m	-1.1m	-1.1m	-1.0m	-947,983	-904,129	-810,824	-644,199	-504,846	-364,341
`14P`	-1.2m	-1.2m	-1.1m	-1.1m	-1.0m	-	-	-	-	-	-	-
Social balance sheet
`9087`	5.4	5.2	5	5.2	5.3	5.1	4.3	4.4	4.2	4.6	4	3.2
Hours worked`1013`	9,208	9,117	8,672	8,860	8,885	8,650	7,460	7,462	7,337	8,202	7,083	5,722
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	abbreviated format	31-08-2026	2026-00478398	PDF
31-12-2024	full format	31-07-2025	2025-00348359	PDF
31-12-2023	full format	30-08-2024	2024-00438672	PDF
31-12-2022	full format	28-08-2023	2023-00376631	PDF
31-12-2021	full format	31-08-2022	2022-20387466	PDF
31-12-2020	full format	26-08-2021	2021-54300410	PDF
31-12-2019	full format	30-10-2020	2020-66200409	PDF
31-12-2018	full format	27-08-2019	2019-52000233	PDF
31-12-2017	full format	31-08-2018	2018-55300251	PDF
31-12-2016	full format	31-08-2017	2017-59600319	PDF
31-12-2015	full format	31-08-2016	2016-51600055	PDF
31-12-2014	full format	31-08-2015	2015-57700373	PDF

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
74,690	42,533	32,934	59,659	43,517	31,278	57,320	10,026	-55,009	-30,024	-31,347	-220,974
24,514	-8,365	-5,890	23,008	13,629	3,509	29,504	-18,126	-89,624	-65,710	-66,862	-252,843
0	0	2,654	0	452	0	875	0	10,073	0	500	718,217
1,545	-34,195	10,809	9,061	-13,730	-62,122	39,631	31,211	9,366	1,732	-57,724	-
-937,689	-1.0m	-1.0m	-1.0m	-998,517	-962,079	-931,380	-854,891	-767,764	-607,016	-474,519	-345,707
-313.0%	-377.7%	-350.2%	-345.6%	-275.4%	-207.3%	-159.2%	-144.3%	-119.1%	-87.1%	-61.5%	-37.4%
0.27	0.23	0.23	0.21	0.22	0.24	0.27	0.26	0.26	0.30	0.35	0.48
0.06	0.05	0.09	0.07	0.07	0.08	0.13	0.11	0.09	0.12	0.12	0.30
6.8%	-2.8%	-12.6%	-14.8%	-14.8%	-13.8%	-7.5%	-15.2%	-25.0%	-19.4%	-17.8%	-39.5%
1.48	0.83	0.83	1.62	1.42	-	-	-	-	-	-	-

Item	31-12-2025	31-12-2024	31-12-2023	31-12-2022	31-12-2021
Employees at the balance-sheet date	6	6	6	5	6
full-time	5	5	5	4	3
part-time	1	1	1	1	3
in full-time equivalents	5.3	5.2	5.5	4.9	5.2
	5.4	5.2	5	5.2	5.3
On a permanent contract	6	5	5	5	5
Joined	3	6	5	4	2
Left	3	6	5	6	2

Item	2025	2024	2023	2022	2021
Tangible fixed assets	-	-	€2,654	-	-
Financial fixed assets	€0	-	-	-	€452
	€133	€133	€35,019	€70,000	€70,000

PHARMA 5

Annual accounts 2025

Balance sheet

in €m

in euro

Position in the sector

-313.0%

0.27

6.8%

Staff

€66,866

level

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on PHARMA 5

Next steps

Annual accounts 2025

Balance sheet

Change in equityin €m

Change in cashin euro

Position in the sector

Solvency-313.0%

Current ratio0.27

Return on assets6.8%

Staff

Staff cost per FTE€66,866

Joined and leftlevel

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on PHARMA 5

Next steps

in €m

in euro

-313.0%

0.27

6.8%

€66,866

level